Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 363246, 8 pages
http://dx.doi.org/10.1155/2012/363246
Review Article

Factors of the Lectin Pathway of Complement Activation and Their Clinical Associations in Neonates

1Laboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland
2National Science Laboratory, Scottish National Blood Transfusion Service, Ellen's Glen Road, Edinburgh EH17 7QT, Scotland, UK

Received 15 September 2011; Revised 12 December 2011; Accepted 30 December 2011

Academic Editor: Misao Matsushita

Copyright © 2012 Maciej Cedzynski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Kemp and D. E. Campbell, “The neonatal immune system,” Seminars in Neonatology, vol. 1, no. 2, pp. 67–75, 1996. View at Google Scholar
  2. A. Stasiak-Barmuta, W. Stankiewicz, M. I. Dabrowski, B. Jurkiewicz, and M. P. Dabrowski, “Distinctions of the neonatal immune system,” Central-European Journal of Immunology, vol. 35, no. 4, pp. 252–258, 2010. View at Google Scholar
  3. A. Sharma, S. Ford, and J. Calvert, “Adaptation for life: a review of neonatal physiology,” Anaesthesia & Intensive Care Medicine, vol. 12, no. 3, pp. 85–90, 2010. View at Publisher · View at Google Scholar
  4. C. A. Siegrist, “The challenges of vaccine responses in early life: selected examples,” Journal of Comparative Pathology, vol. 137, supplement 1, pp. S4–S9, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Sonntag, U. Brandenburg, D. Polzehl et al., “Complement system in healthy term newborns: reference values in umbilical cord blood,” Pediatric and Developmental Pathology, vol. 1, no. 2, pp. 131–135, 1998. View at Google Scholar · View at Scopus
  6. D. Ricklin, G. Hajishengallis, K. Yang, and J. D. Lambris, “Complement: a key system for immune surveillance and homeostasis,” Nature Immunology, vol. 11, no. 9, pp. 785–797, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. U. Amara, M. A. Flierl, D. Rittirsch et al., “Molecular intercommunication between the complement and coagulation systems,” Journal of Immunology, vol. 185, no. 9, pp. 5628–5636, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. C. Ehrnthaller, A. Ignatius, F. Gebhard, and M. Huber-Lang, “New insights of an old defense system: structure, function, and clinical revelance of the complement system,” Molecular Medicine, vol. 17, no. 3-4, pp. 317–329, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. M. V. Carroll and R. B. Sim, “Complement in health and disease,” Advanced Drug Delivery Reviews, vol. 63, no. 12, pp. 965–975, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. K. Oikonomopoulou, D. Ricklin, P. A. Ward, and J. D. Lambris, “Interactions between coagulation and complement—their role in inflammation,” Seminars in Immunopathology, vol. 34, no. 1, pp. 151–165, 2012. View at Publisher · View at Google Scholar · View at PubMed
  11. K. Madalinski, M. Cedzynski, and A. St. Swierzko, “The lectin pathway of complement activation. The role of complement in pathological processes and possible strategies of its activity modulation in therapy of some diseases,” Central-European Journal of Immunology, vol. 28, no. 2, pp. 67–73, 2003. View at Google Scholar
  12. S. Hansen, L. Selman, N. Palaniyar et al., “Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity,” Journal of Immunology, vol. 185, no. 10, pp. 6096–6104, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Matsushita, “The lectin pathway of the complement system,” Microbiology and Immunology, vol. 40, no. 12, pp. 887–893, 1996. View at Google Scholar · View at Scopus
  14. W. Schwaeble, M. R. Dahl, S. Thiel, C. Stover, and J. C. Jensenius, “The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes,” Immunobiology, vol. 205, no. 4-5, pp. 455–466, 2002. View at Google Scholar · View at Scopus
  15. S. Thiel and M. Gadjeva, “Humoral pattern recognition molecules: mannan-binding lectin and ficolins,” Advances in Experimental Medicine and Biology, vol. 653, pp. 58–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. E. Degn, A. G. Hansen, R. Steffensen, C. Jacobsen, J. C. Jensenius, and S. Thiel, “MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation,” Journal of Immunology, vol. 183, no. 11, pp. 7371–7378, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. O. Skjoedt, T. Hummelshoj, Y. Palarasah et al., “A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation,” Journal of Biological Chemistry, vol. 285, no. 11, pp. 8234–8243, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. T. Yongqing, N. Dretin, R. D. Duncan, L. C. Wijeyewickrema, and R. N. Pike, “Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions?” Biochimica et Biophysica Acta, vol. 1824, no. 1, pp. 253–262, 2012. View at Publisher · View at Google Scholar · View at PubMed
  19. M. Matsushita, S. Thiel, J. C. Jensenius, I. Terai, and T. Fujita, “Proteolytic activities of two types of mannose-binding lectin-associated serine protease,” Journal of Immunology, vol. 165, no. 5, pp. 2637–2642, 2000. View at Google Scholar · View at Scopus
  20. V. Rossi, S. Cseh, I. Bally, N. M. Thielens, J. C. Jensenius, and G. J. Arlaud, “Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2,” Journal of Biological Chemistry, vol. 276, no. 44, pp. 40880–40887, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Hajela, M. Kojima, G. Ambrus et al., “The biological functions of MBL-associated serine proteases (MASPs),” Immunobiology, vol. 205, no. 4-5, pp. 467–475, 2002. View at Google Scholar · View at Scopus
  22. M. Moller-Kristensen, S. Thiel, A. Sjoholm, M. Matsushita, and J. C. Jensenius, “Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway,” International Immunology, vol. 19, no. 2, pp. 141–149, 2007. View at Publisher · View at Google Scholar · View at PubMed
  23. A. Kocsis, K. A. Kekesi, R. Szasz et al., “Selective inhibition of the lectin pathway complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation,” Journal of Immunology, vol. 185, no. 7, pp. 4169–4178, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. M. O. Skjoedt, T. Hummelshoj, Y. Palarasah et al., “Serum concentration and interaction properties of MBL/ficolin associated protein-1,” Immunobiology, vol. 216, no. 5, pp. 625–632, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Wallis, “Structural and functional aspects of complement activation by mannose-binding protein,” Immunobiology, vol. 205, no. 4-5, pp. 433–445, 2002. View at Google Scholar · View at Scopus
  26. A. St. Swierzko, M. Cedzynski, T. Kirikae et al., “Role of the complement-lectin pathway in anaphylactoid reaction induced with lipopolysaccharide in mice,” European Journal of Immunology, vol. 33, no. 10, pp. 2842–2852, 2003. View at Publisher · View at Google Scholar · View at PubMed
  27. A. Krarup, R. Wallis, J. S. Presanis, P. Gál, and R. B. Sim, “Simultaneous activation of complement and coagulation by MBL-associated serine protease 2,” PLoS ONE, vol. 2, no. 7, article e623, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. J. Dobo, V. Harmat, L. Beinrohr, E. Sebestyen, P. Zavodszky, and P. Gál, “MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity,” Journal of Immunology, vol. 183, no. 2, pp. 1207–1214, 2009. View at Publisher · View at Google Scholar · View at PubMed
  29. K. C. Gulla, K. Gupta, A. Krarup et al., “Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot,” Immunology, vol. 129, no. 4, pp. 482–495, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. St. Swierzko, A. P. M. Atkinson, M. Cedzynski et al., “Two factors of the lectin pathway of complement, L-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates,” Molecular Immunology, vol. 46, no. 4, pp. 551–558, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. St. Swierzko, M. Cedzynski, I. Domzalska-Popadiuk et al., “Mannan-binding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations,” Molecular Immunology, vol. 46, no. 8-9, pp. 1696–1701, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. S. Sallenbach, S. Thiel, C. Aebi et al., “Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2),” Pediatric Allergy and Immunology, vol. 22, no. 4, pp. 424–430, 2011. View at Publisher · View at Google Scholar · View at PubMed
  33. D. C. Kilpatrick, “Clinical significance of mannan-binding lectin and L-ficolin,” in Collagen-Related Lectins in Innate Immunity, D. Kilpatrick, Ed., pp. 57–84, Research Signpost, Trivandrum, India, 2007. View at Google Scholar
  34. S. Thiel, “Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins,” Molecular Immunology, vol. 44, no. 16, pp. 3875–3888, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. St. Swierzko, A. Szala, M. Cedzynski et al., “Mannan-binding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates,” Human Immunology, vol. 70, no. 1, pp. 68–72, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. Michalski, A. Szala, A. St. Swierzko et al., “H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates,” Immunobiology. In press. View at Publisher · View at Google Scholar · View at PubMed
  37. H. O. Madsen, P. Garred, S. Thiel et al., “Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein,” Journal of Immunology, vol. 155, no. 6, pp. 3013–3020, 1995. View at Google Scholar · View at Scopus
  38. R. Wallis and N. J. Lynch, “Biochemistry and genetics of the collectins,” in Collagen-Related Lectins in Innate Immunity, D. Kilpatrick, Ed., pp. 195–202, Research Signpost, Trivandrum, India, 2007. View at Google Scholar
  39. Y. L. Lau, S. Y. Chan, M. W. Turner, J. Fong, and J. Karlberg, “Mannose-binding protein in preterm infants: developmental profile and clinical significance,” Clinical and Experimental Immunology, vol. 102, no. 3, pp. 649–654, 1995. View at Google Scholar · View at Scopus
  40. S. Kielgast, S. Thiel, T. B. Henriksen, T. Bjerke, J. Olsent, and J. C. Jensenius, “Umbilical cord mannan-binding lectin and infections in early childhood,” Scandinavian Journal of Immunology, vol. 57, no. 2, pp. 167–172, 2003. View at Publisher · View at Google Scholar
  41. A. Hilgendorff, R. Schmidt, A. Bohnert, C. Merz, G. Bein, and L. Gortner, “Host defence lectins in preterm neonates,” Acta Paediatrica, vol. 94, no. 6, pp. 794–799, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. O. A. Bodamer, G. Mitterer, W. Maurer, A. Pollak, M. W. Mueller, and W. M. Schmidt, “Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth,” Genetics in Medicine, vol. 8, no. 8, pp. 518–524, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. F. N. J. Frakking, N. Brouwer, D. Zweers et al., “High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates,” Clinical and Experimental Immunology, vol. 145, no. 1, pp. 5–12, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. M. F. Annells, P. H. Hart, C. G. Mullighan et al., “Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-β, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth,” American Journal of Obstetrics and Gynecology, vol. 191, no. 6, pp. 2056–2067, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. F. E. van de Geijn, A. Roos, Y. A. de Man et al., “Mannose-binding lectin levels during pregnancy: a longitudinal study,” Human Reproduction, vol. 22, no. 2, pp. 362–371, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. F. N. J. Frakking, N. Brouwer, N. K. A. van Eijkelenburg et al., “Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis,” Clinical and Experimental Immunology, vol. 150, no. 2, pp. 255–262, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. F. de Benedetti, C. Auriti, L. E. D'Urbano et al., “Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis,” Pediatric Research, vol. 61, no. 3, pp. 325–328, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. A. B. Dzwonek, O. W. Neth, R. ThiIbaut et al., “The role of mannose-binding lectin in susceptibility to infection in preterm neonates,” Pediatric Research, vol. 63, no. 6, pp. 680–685, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. C. Auriti, G. Prencipe, R. Inglese et al., “Role of mannose-binding lectin in nosocomial sepsis in critically ill neonates,” Human Immunology, vol. 71, no. 11, pp. 1084–1088, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. O. A. Koroglu, H. Onay, G. Erdemir et al., “Mannose-binding lectin gene polymorphism and early neonatal outcome in preterm infants,” Neonatology, vol. 98, no. 4, pp. 305–312, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. O. Ozdemir, E. C. Dinleyici, N. Tekin, O. Colak, and M. A. Aksit, “Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 23, no. 9, pp. 1009–1013, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. W. A. Wahab Mohamed and M. A. Saeed, “Mannose-binding lectin serum levels in neonatal sepsis and septic shock,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 4, pp. 411–414, 2012. View at Google Scholar
  53. H. Özkan, N. Köksal, M. Çetinkaya et al., “Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia,” Journal of Perinatology, vol. 32, no. 3, pp. 210–217, 2012. View at Publisher · View at Google Scholar · View at PubMed
  54. L. J. Schlapbach, M. Mattmann, S. Thiel et al., “Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis,” Clinical Infectious Diseases, vol. 51, no. 2, pp. 153–162, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. C. S. Gibson, A. H. MacLennan, P. N. Goldwater, E. A. Haan, K. Priest, and G. A. Dekker, “Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure,” American Journal of Obstetrics and Gynecology, vol. 198, no. 5, pp. 509.e1–509.e8, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. C. Aydemir, H. Onay, S. S. Oguz et al., “Mannose-binding lectin codon 54 gene polymorphism in relation to risk of nosocomial invasive fungal infection in preterm neonates in the neonatal intensive care unit,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, no. 9, pp. 1124–1127, 2011. View at Publisher · View at Google Scholar · View at PubMed
  57. W. C. van der Zwet, A. Catsburg, R. M. van Elburg, P. H. M. Savelkoul, and C. M. J. E. Vandenbroucke-Grauls, “Mannose-binding lectin (MBL) genotype in relation to risk of nosocomial infection in pre-term neonates in the neonatal intensive care unit,” Clinical Microbiology and Infection, vol. 14, no. 2, pp. 130–135, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. P. Ahrens, E. Kattner, B. Kohler et al., “Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants,” Pediatric Research, vol. 55, no. 4, pp. 652–656, 2004. View at Publisher · View at Google Scholar · View at PubMed
  59. A. Szala, E. Paradowska, D. Nowakowska et al., “Mannan-binding lectin-2 (MBL2) gene polymorphisms in prenatal and perinatal cytomegalovirus infections,” Molecular Immunology, vol. 48, no. 15-16, pp. 2203–2206, 2011. View at Publisher · View at Google Scholar · View at PubMed
  60. A. Hilgendorff, K. Heidinger, A. Pfeiffer et al., “Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants,” Genes and Immunity, vol. 8, no. 8, pp. 671–677, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. E. Capoluongo, G. Vento, S. Rocchetti et al., “Mannose-binding lectin polymorphisms and pulmonary outcome in premature neonates: a pilot study,” Intensive Care Medicine, vol. 33, no. 10, pp. 1787–1794, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. K. Stengaard-Pedersen, S. Thiel, M. Gadjeva et al., “Inherited deficiency of mannan-binding lectin-associated serine protease 2,” New England Journal of Medicine, vol. 349, no. 6, pp. 554–560, 2003. View at Publisher · View at Google Scholar · View at PubMed
  63. S. Thiel, R. Steffensen, I. J. Christensen et al., “Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms,” Genes and Immunity, vol. 8, no. 2, pp. 154–163, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. M. I. Garcia-Laorden, J. Sole-Violan, F. R. de Castro et al., “Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults,” Journal of Allergy and Clinical Immunology, vol. 122, no. 2, pp. 368.e2–374.e2, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. A. B. W. Boldt, C. Grisbach, R. Steffensen et al., “Multiplex sequence-specific polymerase chain reaction reveals new MASP2 haplotypes associated with MASP-2 and MAp19 serum levels,” Human Immunology, vol. 72, no. 9, pp. 753–760, 2011. View at Publisher · View at Google Scholar · View at PubMed
  66. L. J. Schlapbach, C. Aebi, U. Fisch et al., “Higher cord blood levels of mannose-binding lectin-associated serine protease-2 in infants with necrotising enterocolitis,” Pediatric Research, vol. 64, no. 5, pp. 562–566, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. M. Matsushita, “Ficolins: complement-activating lectins involved in innate immunity,” Journal of Innate Immunity, vol. 2, no. 1, pp. 24–32, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. Y. Endo, M. Matsushita, and T. Fujita, “The role of ficolins in the lectin pathway of innate immunity,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 5, pp. 705–712, 2011. View at Publisher · View at Google Scholar · View at PubMed
  69. L. J. Schlapbach, U. Kessler, S. Thiel et al., “M-ficolin in the neonatal period: associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis,” Molecular Immunology, vol. 46, no. 13, pp. 2597–2603, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. T. Hummelshoj, L. Munthe-Fog, H. O. Madsen, and P. Garred, “Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns,” Molecular Immunology, vol. 45, no. 9, pp. 2508–2520, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. P. Garred, C. Honore, Y. J. Ma et al., “The genetics of ficolins,” Journal of Innate Immunity, vol. 2, no. 1, pp. 3–16, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. D. C. Kilpatrick, T. Fujita, and M. Matsushita, “P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients,” Immunology Letters, vol. 67, no. 2, pp. 109–112, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Munthe-Fog, T. Hummelshoj, B. E. Hansen et al., “The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels,” Scandinavian Journal of Immunology, vol. 65, no. 4, pp. 383–392, 2007. View at Publisher · View at Google Scholar · View at PubMed
  74. M. Cedzynski, L. Nuytinck, A. P. M. Atkinson et al., “Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene,” Clinical and Experimental Immunology, vol. 150, no. 1, pp. 99–104, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. L. J. Schlapbach, S. Thiel, U. Kessler, R. A. Ammann, C. Aebi, and J. C. Jensenius, “Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis,” Gut, vol. 60, no. 10, pp. 1438–1439, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. L. Munthe-Fog, T. Hummelshoj, C. Honore, H. O. Madsen, H. Permin, and P. Garred, “Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency,” New England Journal of Medicine, vol. 360, no. 25, pp. 2637–2644, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. L. Munthe-Fog, T. Hummelshoj, Y. J. Ma et al., “Characterization of a polymorphism in the coding sequence of FCN3 resulting in ficolin-3 (Hakata antigen) deficiency state,” Molecular Immunology, vol. 45, no. 9, pp. 2660–2666, 2008. View at Publisher · View at Google Scholar · View at PubMed